Nanomaterials for targeted therapy of kidney diseases: Strategies and advances
The treatment and management of kidney diseases pose a significant global burden. Due to the presence of blood circulation barriers and glomerular filtration barriers, drug therapy for kidney diseases faces challenges such as poor renal targeting, short half-life, and severe systemic side effects, s...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Materials Today Bio |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425000924 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540378888142848 |
|---|---|
| author | Zhiwen Wang Chun Zhang |
| author_facet | Zhiwen Wang Chun Zhang |
| author_sort | Zhiwen Wang |
| collection | DOAJ |
| description | The treatment and management of kidney diseases pose a significant global burden. Due to the presence of blood circulation barriers and glomerular filtration barriers, drug therapy for kidney diseases faces challenges such as poor renal targeting, short half-life, and severe systemic side effects, severely hindering therapeutic progress. Therefore, the research and development of kidney-targeted therapeutic agents is of great clinical significance. In recent years, the application of nanotechnology in the field of nephrology has shown potential for revolutionizing the diagnosis and treatment of kidney diseases. Carefully designed nanomaterials can exhibit optimal biological characteristics, influencing various aspects such as circulation, retention, targeting, and excretion. Rationally designing and modifying nanomaterials based on the anatomical structure and pathophysiological environment of the kidney to achieve highly specific kidney-targeted nanomaterials or nanodrug delivery systems is both feasible and promising. Based on the targeted therapy of kidney diseases, this review discusses the advantages and limitations of current nanomedicine in the targeted therapy of kidney diseases, and summarizes the application and challenges of current renal active/passive targeting strategies, in order to further promote the development of kidney-targeted nanomedicine through a preliminary summary of previous studies and future prospects. |
| format | Article |
| id | doaj-art-31835178dc3943a5a01fe87e52e0ecc0 |
| institution | Kabale University |
| issn | 2590-0064 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Materials Today Bio |
| spelling | doaj-art-31835178dc3943a5a01fe87e52e0ecc02025-02-05T04:32:35ZengElsevierMaterials Today Bio2590-00642025-04-0131101534Nanomaterials for targeted therapy of kidney diseases: Strategies and advancesZhiwen Wang0Chun Zhang1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, ChinaCorresponding author.; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, ChinaThe treatment and management of kidney diseases pose a significant global burden. Due to the presence of blood circulation barriers and glomerular filtration barriers, drug therapy for kidney diseases faces challenges such as poor renal targeting, short half-life, and severe systemic side effects, severely hindering therapeutic progress. Therefore, the research and development of kidney-targeted therapeutic agents is of great clinical significance. In recent years, the application of nanotechnology in the field of nephrology has shown potential for revolutionizing the diagnosis and treatment of kidney diseases. Carefully designed nanomaterials can exhibit optimal biological characteristics, influencing various aspects such as circulation, retention, targeting, and excretion. Rationally designing and modifying nanomaterials based on the anatomical structure and pathophysiological environment of the kidney to achieve highly specific kidney-targeted nanomaterials or nanodrug delivery systems is both feasible and promising. Based on the targeted therapy of kidney diseases, this review discusses the advantages and limitations of current nanomedicine in the targeted therapy of kidney diseases, and summarizes the application and challenges of current renal active/passive targeting strategies, in order to further promote the development of kidney-targeted nanomedicine through a preliminary summary of previous studies and future prospects.http://www.sciencedirect.com/science/article/pii/S2590006425000924 |
| spellingShingle | Zhiwen Wang Chun Zhang Nanomaterials for targeted therapy of kidney diseases: Strategies and advances Materials Today Bio |
| title | Nanomaterials for targeted therapy of kidney diseases: Strategies and advances |
| title_full | Nanomaterials for targeted therapy of kidney diseases: Strategies and advances |
| title_fullStr | Nanomaterials for targeted therapy of kidney diseases: Strategies and advances |
| title_full_unstemmed | Nanomaterials for targeted therapy of kidney diseases: Strategies and advances |
| title_short | Nanomaterials for targeted therapy of kidney diseases: Strategies and advances |
| title_sort | nanomaterials for targeted therapy of kidney diseases strategies and advances |
| url | http://www.sciencedirect.com/science/article/pii/S2590006425000924 |
| work_keys_str_mv | AT zhiwenwang nanomaterialsfortargetedtherapyofkidneydiseasesstrategiesandadvances AT chunzhang nanomaterialsfortargetedtherapyofkidneydiseasesstrategiesandadvances |